EPIZYME, INC. Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31)
EPIZYME, INC. had Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) of $203.75 million as of 2018-06-30, per its 10-Q filed 2018-08-02.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:AssetsFairValueDisclosureRecurring · last filed 2018-08-02
- 2018-06-30: Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $203.75M.
- 2018-03-31: Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $232.56M.
- 2017-12-31: Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $257.03M.
- 2017-09-30: Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $291.30M.
| Period end | Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) |
|---|---|
| 2018-06-30 | $203.75M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $232.56M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $257.03M 10-Q · filed 2018-08-02 |
| 2017-09-30 | $291.30M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $168.07M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $202.42M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $227.15M 10-K · filed 2018-03-13 |
| 2016-09-30 | $241.57M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $279.33M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $297.27M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $197.02M 10-K · filed 2017-03-13 |
| 2015-09-30 | $196.97M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $196.92M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $196.88M 10-Q · filed 2015-04-28 |
| 2014-12-31 | $184.26M 10-K · filed 2016-03-09 |
| 2014-09-30 | $199.53M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $222.01M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $221.99M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $121.42M 10-K · filed 2015-03-12 |
| 2013-09-30 | $121.41M 10-Q · filed 2013-10-23 |
| 2013-06-30 | $121.39M 10-Q · filed 2013-08-01 |
| 2012-12-31 | $97.38M 10-K · filed 2014-02-28 |